[
  {
    "ts": null,
    "headline": "8MM Alzheimer's Disease Market Drug Forecast and Market Analysis 2025-2033 | Eisai, Biogen, and Lilly to Lead, Novel Late-stage Pipeline Drugs Will Be a Key Driver, Opportunities in Unmet Needs",
    "summary": "Alzheimer’s market growth opportunities lie in developing disease-modifying treatments and anti-Aβ monoclonal antibodies, driven by unmet needs in AD therapies. The US and China dominate sales, with future expansions anticipated, requiring strategic in-licensing, partnerships, and innovation to capture growing demand.Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The \"Alzheimer's Disease: Eight-Market Drug Forecast and Market Analysis - Update\" report has been added to ResearchAndMarkets.com's offer",
    "url": "https://finnhub.io/api/news?id=aaad952cbb15e2f4f9d4507cc0b93b4e08e3c1f357fa18da6911de439d32c95e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757516580,
      "headline": "8MM Alzheimer's Disease Market Drug Forecast and Market Analysis 2025-2033 | Eisai, Biogen, and Lilly to Lead, Novel Late-stage Pipeline Drugs Will Be a Key Driver, Opportunities in Unmet Needs",
      "id": 136688583,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Alzheimer’s market growth opportunities lie in developing disease-modifying treatments and anti-Aβ monoclonal antibodies, driven by unmet needs in AD therapies. The US and China dominate sales, with future expansions anticipated, requiring strategic in-licensing, partnerships, and innovation to capture growing demand.Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The \"Alzheimer's Disease: Eight-Market Drug Forecast and Market Analysis - Update\" report has been added to ResearchAndMarkets.com's offer",
      "url": "https://finnhub.io/api/news?id=aaad952cbb15e2f4f9d4507cc0b93b4e08e3c1f357fa18da6911de439d32c95e"
    }
  }
]